Skip to content

How Alliance Works

Membership
Leadership & Administration
Mission and History
Group Meetings
Careers
Support Our Work

Programs & Committees

Programs
Committees

Clinical Trials & Research

Clinical Trials
Trial Pathways
International Collaborations
Specimen Bank and Data Sharing Requests
Publications
Past Trial and Result Summaries
Safety and Standards
Alliance Data Innovation Lab

Search

Contact
Donate
News

Search

How Alliance Works
Programs & Committees
Clinical Trials & Research
Patients

Home
Multiple Myeloma & Plasma Cell Disorders
Page 2

Multiple Myeloma & Plasma Cell Disorders

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

September 26, 2026

Myeloma
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma

September 26, 2026

Leukemia
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

September 26, 2026

1 2

Categories

Alliance Committee

Browse by Year

About
Contact
Disclaimer
Trials
Careers

Facebook
X
YouTube
LinkedIn

Copyright © 2026